fullerene c60 has been researched along with triphenyltetrazolium in 1 studies
| Studies (fullerene c60) | Trials (fullerene c60) | Recent Studies (post-2010) (fullerene c60) | Studies (triphenyltetrazolium) | Trials (triphenyltetrazolium) | Recent Studies (post-2010) (triphenyltetrazolium) |
|---|---|---|---|---|---|
| 3,806 | 5 | 2,170 | 707 | 1 | 115 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, YC; Chen, IL; Cheng, FC; Lee, MS; Wang, MF; Yang, DY | 1 |
1 other study(ies) available for fullerene c60 and triphenyltetrazolium
| Article | Year |
|---|---|
Systemic administration of a water-soluble hexasulfonated C(60) (FC(4)S) reduces cerebral ischemia-induced infarct volume in gerbils.
Topics: Animals; Brain Ischemia; Carbon; Free Radical Scavengers; Fullerenes; Gerbillinae; Infarction, Middle Cerebral Artery; Male; Motor Activity; Neuroprotective Agents; Oxidative Stress; Solubility; Tetrazolium Salts; Water | 2001 |